SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 6-K

                        REPORT OF FOREIGN PRIVATE ISSUER



                    Pursuant to Rule 13a-16 or 15d-16 of the

                         Securities Exchange Act of 1934



                          For the month of October 2005


                       FRESENIUS MEDICAL CARE CORPORATION

                 (Translation of registrant's name into English)



                              Else-Kroner Strasse 1

                                61346 Bad Homburg

                                     Germany

                    (Address of principal executive offices)



       Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.

       Form 20-F  [X]             Form 40-F  [ ]

       Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1): [ ]

       Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7): [ ]

       Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the information to
the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.

       Yes  [ ]                   No  [X]

       If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b): 82



     This Report on Form 6-K shall be incorporated by reference in the
Registration Statement on Form F-4 (Registration No. 333-128899) filed October
7, 2005 by Fresenius Medical Care AG (the "Company") and shall be part thereof
and the prospectus included therein from the date on which this report is filed,
to the extent not superseded by documents or reports subsequently filed or
furnished by the Company with the U.S. Securities and Exchange Commission.

     Attached hereto as Exhibit 99.1 is an Investors News release issued on
October 10, 2005 announcing legal actions taken against resolutions of the Extra
Ordinary General Meeting.




                                    EXHIBITS

    Exhibit 99.1           Investors News release issued October 10, 2005

                                       2


                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.



DATE: October 11, 2005



                                       FRESENIUS MEDICAL CARE
                                       AKTIENGESELLSCHAFT

                                       By: /s/ BEN LIPPS
                                           -------------------------------------
                                           Name:  Dr. Ben Lipps
                                           Title: Chief Executive Officer and
                                           Chairman of the Management Board



                                       By: /s/ LAWRENCE A. ROSEN
                                           -------------------------------------
                                           Name:  Lawrence A. Rosen
                                           Title: Chief Financial Officer

                                       3